Lung cancer screening technology can be described as the software offering designed to automate healthcare facilities ' workflow by gathering all the testing results from CT, X-Ray and MRI machines. They are mainly done so they can easily detect the cancer and reduce their symptoms. Implementation of this software helps to better track patients, evaluate the stage of the disease, next step of action, report and keep patient information systemized.
The Global Lung Cancer Screening Software Market is segmented on the Geography as North America, Europe, Asia-Pacific, South America, Middle East and Africa
“According to Data Bridge Market Research, Global Lung Cancer Screening Software Market is set to register a healthy CAGR of 19.63% in the forecast period of 2019-2026”
Few of the major competitors currently working in the global lung cancer screening software market are PENRAD TECHNOLOGIES, INC.; Eon; Koninklijke Philips N.V.; Kheiron Medical Technologies; Volpara Solutions Limited; Thynk Health; CRA Health LLC; ProVation Medical, Inc.; Nuance Communications, Inc.; Siemens Healthcare GmbH; CureMetrix, Inc.; MyCareWare Inc.; MobileODT; MRS Systems, Inc.; Lungview and Vital Images among others.
Rising cases of lung cancer and increasing screening programs worldwide is the factor for the market growth. Growing awareness about the early stage of diagnosis will also affect the market growth. A large number of clinical trials, studies and demonstration projects are carried out worldwide to assess the effectiveness of screening programs; this factor is also expected to enhance the market growth. Government is also taking many initiatives so they can implement different screening programs which will also affect the market growth positively. These are some of the factors which will affect the market growth and enhance its demand.
Browse in Healthcare Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/
Global Lung Cancer Screening Software Market – Industry Trends and Forecast to 2026